Article
BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients.
Journal of immunology research - 1 Jan 2015
Lindberg Ulrika, Carlsson Malin, Hellmark Thomas, Segelmark Mårten
Abstract excerpt
Patients with cystic fibrosis (CF) colonized with Pseudomonas aeruginosa (P. aeruginosa) have worse prognosis compared with patients who are not. BPI-ANCA is an anti-neutrophil cytoplasmic antibody against BPI (bactericidal/permeability increasing protein) correlating with P. aeruginosa colonizat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
